Previous 10 | Next 10 |
2023-05-09 18:03:18 ET Psychemedics press release ( NASDAQ: PMD ): Q1 GAAP EPS of -$0.07. Revenue of $5.9M (-9.2% Y/Y). For further details see: Psychemedics GAAP EPS of -$0.07, revenue of $5.9M
ACTON, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March 31, 2023, and the declaration of a cash dividend of $0.07 per share to...
2023-03-21 17:27:41 ET Psychemedics press release ( NASDAQ: PMD ): Q4 GAAP EPS of -$0.12. Revenue of $5.7M (-11.5% Y/Y). For further details see: Psychemedics GAAP EPS of -$0.12, revenue of $5.7M
ACTON, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, announced today fourth quarter and full year financial results for the period ended December 31, 2022. The Company also announced a quar...
Psychemedics press release ( NASDAQ: PMD ): Q3 GAAP EPS of -$0.02. Revenue of $6.5M (-3.0% Y/Y). For further details see: Psychemedics GAAP EPS of -$0.02, revenue of $6.5M
Psychemedics ( NASDAQ: PMD ) declares $0.07/share quarterly dividend , in line with previous. Forward yield 4.45% Payable Dec. 16; for shareholders of record Dec. 2; ex-div Dec. 1. See PMD Dividend Scorecard, Yield Chart, & Dividend Growth. For fu...
ACTON, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the third quarter ended September 30, 2022. The Company also announced a cash quarterly divid...
Psychemedics press release ( NASDAQ: PMD ): Q2 GAAP EPS of -$0.06. Revenue of $6.51M (+6.9% Y/Y). For further details see: Psychemedics GAAP EPS of -$0.06, revenue of $6.51M
ACTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the second quarter ended June 30, 2022. The Company also announced a quarterly dividend of $0...
ACTON, Mass., June 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced today that it will be nominating Peter H. Kamin and Darius G. Nevin to serve as new members of its Board of Directors at its upcoming Annual Meeting of Stockholders to be held on Augus...
News, Short Squeeze, Breakout and More Instantly...
Psychemedics Corporation Company Name:
PMD Stock Symbol:
NASDAQ Market:
Psychemedics Corporation Website:
DALLAS, May 14, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s leading provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March 31, 2024. The Company’s revenue for the quarter ended March 31,...
DALLAS, March 28, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s leading provider of hair testing for drugs of abuse, announced today financial results for the year ended December 31, 2023. “2023 proved to be another challenging year due to the nega...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...